Executive Summery

This report presents a detailed overview of the Single-use Pumps in the Biopharmaceutical Market, highlighting key insights into its market size, share, and growth during the forecast period, i.e., 2022-27. It explores emerging trends, competitive dynamics, and the core drivers reshaping the industry. Backed by solid data and expert analysis, the study offers segment-wise insights and reliable forecasts to guide strategic decisions. With comprehensive market analysis and forward-looking perspectives, this report serves as a practical tool for stakeholders navigating change. Whether you're an investor, policymaker, or business leader, this research helps you stay ahead in the fast-evolving Single-use Pumps in the Biopharmaceutical industry landscape.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Download your free sample PDF of the report– https://www.marknteladvisors.com/query/request-sample/single-use-pumps-in-biopharmaceutical-market.html

Single-use Pumps in the Biopharmaceutical Market Statistics and Key Highlights

The Global Single-use Pumps in the Biopharmaceutical market is projected to grow at a CAGR of around 6.21% during the forecast period, 2022-2027. 

  • Single-use Pumps in the Biopharmaceutical market shows steady growth
  • Market size expanding due to rising industry demand
  • Competitive landscape driven by tech and innovation
  • Detailed segment-wise and geography wise share analysis
  • Forecast reveals strong trends shaping future outlook

Key Player- Emerging Single-use Pumps in the Biopharmaceutical Companies

  • PSG Dover
  • Quantex Arc
  • Watson Marlow
  • Colly Flowtech AB
  • Levitronix
  • PumpCell
  • Fluid Flow
  • PROMECON GmbH
  • CerCell
  • ALMATECHNIK AG
  • Verder International B.V.
  • ProMinent GmbH
  • Others

Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/single-use-pumps-in-biopharmaceutical-market.html

Use your official business email to connect with our team and enjoy full access with priority support.

Key Driver:

Biopharmaceutical product manufacturing is rapidly growing & becoming increasingly competitive. The success of the clinical pipeline has led to an unprecedented number of new biologic launches & an increase in the share of new approvals from the U.S Food and Drug Administration. In addition to this, there has been significant growth in the research & development of orphan drugs as well. According to the European Medicines Agency statistics, 207 initial orphan marketing authorizations have been granted & 126 active initial authorizations of orphan drugs are to be marketed as of 2022. Therefore, the clinical research, as well as commercial manufacturing of orphan & niche drugs, would witness a substantial increase in the coming years.

Further, with the increasing market for a biosimilar, orphan drugs, and other biopharmaceutical products, the demand for single-use systems such as bioreactors, pumps, containers, etc., for clinical as well as commercial purposes would experience a significant uptick in demand during the forecasted years.

Looking for Global, Regional or country-specific reports on this market?

Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support -  https://www.marknteladvisors.com/query/request-customization/single-use-pumps-in-biopharmaceutical-market.html

Single-use Pumps in the Biopharmaceutical Market Segmentation

By Type

  • Peristaltic pumps
  • Diaphragm pumps
  • Rotary lobe pumps
  • Piston pumps

By Material

  • Polypropylene (PP)
  • Polyethylene (PE)

Of them all, the demand for single-use pumps constructed from solid Polypropylene (PP) experienced a notable rise during the historical period, 2017-2021, on account of its wide utilization in the biopharmaceutical industry as it offers high resistance to a broad range of solutions, leachable & can be used even at high temperatures. 

By Application

  • Clinical
  • Commercial

By Bioprocessing             

  • Upstream bioprocessing
  • Downstream Bioprocessing

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Of all the regions globally, North America held a considerable market share during the historical period, owing to the growing R&D investments in biopharma product development. 

Reasons to Buy This Report

  1. Gain comprehensive insights into current market trends and dynamics.
  2. Equip your business with data-driven strategies for informed decisions.
  3. Identify lucrative market opportunities and strategic growth areas.
  4. Analyze competitors to enhance your positioning in the market landscape.
  5. Understand geographical trends across diverse markets for better expansion strategies.

Other reports

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiries: sales@marknteladvisors.com